Scenic Biotech Employee Directory
Biotechnology ResearchNorth Holland, Netherlands11-50 Employees
Scenic Biotech's lead program addresses lysosomal storage disorders and neurodegeneration. A first in class break through that is about to enter clinical development. Scenic's robust pipeline for neurometabolic diseases is derived from its proprietary Cell-Seq discovery platform. In addition, the platform is leveraged through strategic R&D collaborations with Genentech, BMS, Alnylam and Ono. By unlocking new pathways in the genome, Scenic Biotech is developing a range of modifier therapies to help patients.